Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.

The makers of two popular weight-loss drugs—Wegovy and Zepbound—are cutting prices to make the medications more affordable ...

NovoCare Pharmacy will provide all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients ...

Novo Nordisk said on Wednesday it would offer doses of its weight-loss drug Wegovy at a reduced cost of $499 per month for ...

People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...

The U.S. Food and Drug Administration declared that the shortage of Novo Nordisk’s NOVO.B0.51%increase; green up pointing triangle weight-loss medications Wegovy and Ozempic has been resolved ...

The Food and Drug Administration said Friday that drugmaker Novo Nordisk ... that drugmaker Novo Nordisk can meet present and future demand in the US Shortages of Ozempic and Wegovy that have ...

Shortages of Ozempic and Wegovy that have been in place ... federal regulators said Friday.The drugmaker Novo Nordisk can meet current and future demand in the U.S., the Food and Drug ...

Ozempic and Wegovy, the widely popular forms ... to sell copycat versions of the drugs while they were in shortage. Novo Nordisk, the manufacturer of semaglutide, confirmed in a statement Friday ...